Compile Data Set for Download or QSAR
maximum 50k data
Found 36 Enz. Inhib. hit(s) with all data for entry = 6490
TargetCholinesterase(Homo sapiens (Human))
Uniwersytet Warszawski

US Patent
LigandPNGBDBM132084(US8841453, 15)
Affinity DataIC50:  0.240nMAssay Description:The biological activity of the compounds of general formula (I) towards the cholinesterase inhibition was evaluated using Ellman's method (Ellman, G....More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCholinesterase(Homo sapiens (Human))
Uniwersytet Warszawski

US Patent
LigandPNGBDBM132071(US8841453, 1)
Affinity DataIC50:  0.25nMAssay Description:The biological activity of the compounds of general formula (I) towards the cholinesterase inhibition was evaluated using Ellman's method (Ellman, G....More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCholinesterase(Homo sapiens (Human))
Uniwersytet Warszawski

US Patent
LigandPNGBDBM132080(US8841453, 11)
Affinity DataIC50:  0.25nMAssay Description:The biological activity of the compounds of general formula (I) towards the cholinesterase inhibition was evaluated using Ellman's method (Ellman, G....More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCholinesterase(Homo sapiens (Human))
Uniwersytet Warszawski

US Patent
LigandPNGBDBM132083(US8841453, 14)
Affinity DataIC50:  0.280nMAssay Description:The biological activity of the compounds of general formula (I) towards the cholinesterase inhibition was evaluated using Ellman's method (Ellman, G....More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCholinesterase(Homo sapiens (Human))
Uniwersytet Warszawski

US Patent
LigandPNGBDBM132074(US8841453, 4)
Affinity DataIC50:  0.380nMAssay Description:The biological activity of the compounds of general formula (I) towards the cholinesterase inhibition was evaluated using Ellman's method (Ellman, G....More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCholinesterase(Homo sapiens (Human))
Uniwersytet Warszawski

US Patent
LigandPNGBDBM132088(US8841453, 17)
Affinity DataIC50:  0.780nMAssay Description:The biological activity of the compounds of general formula (I) towards the cholinesterase inhibition was evaluated using Ellman's method (Ellman, G....More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCholinesterase(Homo sapiens (Human))
Uniwersytet Warszawski

US Patent
LigandPNGBDBM132081(US8841453, 12)
Affinity DataIC50:  0.880nMAssay Description:The biological activity of the compounds of general formula (I) towards the cholinesterase inhibition was evaluated using Ellman's method (Ellman, G....More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAcetylcholinesterase(Homo sapiens (Human))
Uniwersytet Warszawski

US Patent
LigandPNGBDBM132083(US8841453, 14)
Affinity DataIC50:  1.18nMAssay Description:The biological activity of the compounds of general formula (I) towards the cholinesterase inhibition was evaluated using Ellman's method (Ellman, G....More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCholinesterase(Homo sapiens (Human))
Uniwersytet Warszawski

US Patent
LigandPNGBDBM132086(US8841453, 18)
Affinity DataIC50:  1.20nMAssay Description:The biological activity of the compounds of general formula (I) towards the cholinesterase inhibition was evaluated using Ellman's method (Ellman, G....More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCholinesterase(Homo sapiens (Human))
Uniwersytet Warszawski

US Patent
LigandPNGBDBM132087(US8841453, 19)
Affinity DataIC50:  1.31nMAssay Description:The biological activity of the compounds of general formula (I) towards the cholinesterase inhibition was evaluated using Ellman's method (Ellman, G....More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAcetylcholinesterase(Homo sapiens (Human))
Uniwersytet Warszawski

US Patent
LigandPNGBDBM132085(US8841453, 16)
Affinity DataIC50:  1.43nMAssay Description:The biological activity of the compounds of general formula (I) towards the cholinesterase inhibition was evaluated using Ellman's method (Ellman, G....More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCholinesterase(Homo sapiens (Human))
Uniwersytet Warszawski

US Patent
LigandPNGBDBM132085(US8841453, 16)
Affinity DataIC50:  1.64nMAssay Description:The biological activity of the compounds of general formula (I) towards the cholinesterase inhibition was evaluated using Ellman's method (Ellman, G....More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCholinesterase(Homo sapiens (Human))
Uniwersytet Warszawski

US Patent
LigandPNGBDBM132073(US8841453, 3)
Affinity DataIC50:  2.04nMAssay Description:The biological activity of the compounds of general formula (I) towards the cholinesterase inhibition was evaluated using Ellman's method (Ellman, G....More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCholinesterase(Homo sapiens (Human))
Uniwersytet Warszawski

US Patent
LigandPNGBDBM132079(US8841453, 10)
Affinity DataIC50:  2.07nMAssay Description:The biological activity of the compounds of general formula (I) towards the cholinesterase inhibition was evaluated using Ellman's method (Ellman, G....More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCholinesterase(Homo sapiens (Human))
Uniwersytet Warszawski

US Patent
LigandPNGBDBM132076(US8841453, 7)
Affinity DataIC50:  3.15nMAssay Description:The biological activity of the compounds of general formula (I) towards the cholinesterase inhibition was evaluated using Ellman's method (Ellman, G....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAcetylcholinesterase(Homo sapiens (Human))
Uniwersytet Warszawski

US Patent
LigandPNGBDBM132084(US8841453, 15)
Affinity DataIC50:  3.80nMAssay Description:The biological activity of the compounds of general formula (I) towards the cholinesterase inhibition was evaluated using Ellman's method (Ellman, G....More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCholinesterase(Homo sapiens (Human))
Uniwersytet Warszawski

US Patent
LigandPNGBDBM132072(US8841453, 2)
Affinity DataIC50:  4.28nMAssay Description:The biological activity of the compounds of general formula (I) towards the cholinesterase inhibition was evaluated using Ellman's method (Ellman, G....More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAcetylcholinesterase(Homo sapiens (Human))
Uniwersytet Warszawski

US Patent
LigandPNGBDBM132080(US8841453, 11)
Affinity DataIC50:  4.61nMAssay Description:The biological activity of the compounds of general formula (I) towards the cholinesterase inhibition was evaluated using Ellman's method (Ellman, G....More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAcetylcholinesterase(Homo sapiens (Human))
Uniwersytet Warszawski

US Patent
LigandPNGBDBM132088(US8841453, 17)
Affinity DataIC50:  7nMAssay Description:The biological activity of the compounds of general formula (I) towards the cholinesterase inhibition was evaluated using Ellman's method (Ellman, G....More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAcetylcholinesterase(Homo sapiens (Human))
Uniwersytet Warszawski

US Patent
LigandPNGBDBM132074(US8841453, 4)
Affinity DataIC50:  7.70nMAssay Description:The biological activity of the compounds of general formula (I) towards the cholinesterase inhibition was evaluated using Ellman's method (Ellman, G....More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAcetylcholinesterase(Homo sapiens (Human))
Uniwersytet Warszawski

US Patent
LigandPNGBDBM132086(US8841453, 18)
Affinity DataIC50:  8.10nMAssay Description:The biological activity of the compounds of general formula (I) towards the cholinesterase inhibition was evaluated using Ellman's method (Ellman, G....More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCholinesterase(Homo sapiens (Human))
Uniwersytet Warszawski

US Patent
LigandPNGBDBM132082(US8841453, 13)
Affinity DataIC50:  8.20nMAssay Description:The biological activity of the compounds of general formula (I) towards the cholinesterase inhibition was evaluated using Ellman's method (Ellman, G....More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCholinesterase(Homo sapiens (Human))
Uniwersytet Warszawski

US Patent
LigandPNGBDBM132078(US8841453, 9)
Affinity DataIC50:  15.5nMAssay Description:The biological activity of the compounds of general formula (I) towards the cholinesterase inhibition was evaluated using Ellman's method (Ellman, G....More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAcetylcholinesterase(Homo sapiens (Human))
Uniwersytet Warszawski

US Patent
LigandPNGBDBM132075(US8841453, 5)
Affinity DataIC50:  20.1nMAssay Description:The biological activity of the compounds of general formula (I) towards the cholinesterase inhibition was evaluated using Ellman's method (Ellman, G....More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAcetylcholinesterase(Homo sapiens (Human))
Uniwersytet Warszawski

US Patent
LigandPNGBDBM132087(US8841453, 19)
Affinity DataIC50:  25.6nMAssay Description:The biological activity of the compounds of general formula (I) towards the cholinesterase inhibition was evaluated using Ellman's method (Ellman, G....More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAcetylcholinesterase(Homo sapiens (Human))
Uniwersytet Warszawski

US Patent
LigandPNGBDBM132071(US8841453, 1)
Affinity DataIC50:  33.8nMAssay Description:The biological activity of the compounds of general formula (I) towards the cholinesterase inhibition was evaluated using Ellman's method (Ellman, G....More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCholinesterase(Homo sapiens (Human))
Uniwersytet Warszawski

US Patent
LigandPNGBDBM132075(US8841453, 5)
Affinity DataIC50:  34.5nMAssay Description:The biological activity of the compounds of general formula (I) towards the cholinesterase inhibition was evaluated using Ellman's method (Ellman, G....More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAcetylcholinesterase(Homo sapiens (Human))
Uniwersytet Warszawski

US Patent
LigandPNGBDBM132076(US8841453, 7)
Affinity DataIC50:  36.8nMAssay Description:The biological activity of the compounds of general formula (I) towards the cholinesterase inhibition was evaluated using Ellman's method (Ellman, G....More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAcetylcholinesterase(Homo sapiens (Human))
Uniwersytet Warszawski

US Patent
LigandPNGBDBM132081(US8841453, 12)
Affinity DataIC50:  39.9nMAssay Description:The biological activity of the compounds of general formula (I) towards the cholinesterase inhibition was evaluated using Ellman's method (Ellman, G....More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCholinesterase(Homo sapiens (Human))
Uniwersytet Warszawski

US Patent
LigandPNGBDBM132077(US8841453, 8)
Affinity DataIC50:  58.2nMAssay Description:The biological activity of the compounds of general formula (I) towards the cholinesterase inhibition was evaluated using Ellman's method (Ellman, G....More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAcetylcholinesterase(Homo sapiens (Human))
Uniwersytet Warszawski

US Patent
LigandPNGBDBM132073(US8841453, 3)
Affinity DataIC50:  178nMAssay Description:The biological activity of the compounds of general formula (I) towards the cholinesterase inhibition was evaluated using Ellman's method (Ellman, G....More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAcetylcholinesterase(Homo sapiens (Human))
Uniwersytet Warszawski

US Patent
LigandPNGBDBM132079(US8841453, 10)
Affinity DataIC50:  186nMAssay Description:The biological activity of the compounds of general formula (I) towards the cholinesterase inhibition was evaluated using Ellman's method (Ellman, G....More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAcetylcholinesterase(Homo sapiens (Human))
Uniwersytet Warszawski

US Patent
LigandPNGBDBM132077(US8841453, 8)
Affinity DataIC50:  270nMAssay Description:The biological activity of the compounds of general formula (I) towards the cholinesterase inhibition was evaluated using Ellman's method (Ellman, G....More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAcetylcholinesterase(Homo sapiens (Human))
Uniwersytet Warszawski

US Patent
LigandPNGBDBM132078(US8841453, 9)
Affinity DataIC50:  378nMAssay Description:The biological activity of the compounds of general formula (I) towards the cholinesterase inhibition was evaluated using Ellman's method (Ellman, G....More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAcetylcholinesterase(Homo sapiens (Human))
Uniwersytet Warszawski

US Patent
LigandPNGBDBM132072(US8841453, 2)
Affinity DataIC50:  1.10E+3nMAssay Description:The biological activity of the compounds of general formula (I) towards the cholinesterase inhibition was evaluated using Ellman's method (Ellman, G....More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAcetylcholinesterase(Homo sapiens (Human))
Uniwersytet Warszawski

US Patent
LigandPNGBDBM132082(US8841453, 13)
Affinity DataIC50:  3.28E+3nMAssay Description:The biological activity of the compounds of general formula (I) towards the cholinesterase inhibition was evaluated using Ellman's method (Ellman, G....More data for this Ligand-Target Pair
In DepthDetails US Patent